2020-05-08 Yuanyuan Wang
Prof dr E Hak
Prof dr M Boezen
Effectiveness and safety of medicines used in COPD patients: pharmacoepidemiological studies

2020-02-24 Ivan Pradipta
Prof de E Hak
Prof dr JW Alffenaar
Improving treatment outcomes of tuberculosis: towards an antimicrobial stewardship program

2020-02-10 Ira Sianturi
Prof dr K Taxis
Prof dr B Wilffert
Exploring strategies to optimize pharmacotherapy with antiretrovirals in Papuans living with HIV

2019-03-22 Heleen van der Meer
Prof dr K Taxis
Prof dr LG Pont
Describing in older people. Development and evaluation of complex healthcare interventions

2018-12-21 Willem van der Veen
Prof dr K Taxis
Prof dr PMLA van den Bemt
Prof dr JJ de Gier
Information technology and medication safety

2018-11-30 Mirjam Simoons
Prof dr EN van Roon
Prof dr RA Schoevers
Somatic monitoring of patients with mood and anxiety disorders: Problem definition, implementation and further explorations

2018-09-14 Maarten van Wijhe
Prof dr MJ Postma
Prof dr J Wallinga
The public health impact of vaccination programmes in the Netherlands

2018-06-29 Ury Arifin
Prof dr MJ Postma
Distress and health-related quality of life in Indonesian type 2 diabetes mellitus outpatients

2018-06-25 Neily Zakiyah
Prof dr MJ Postma
Women's health from a global economic perspective

2018-03-23 Leàn Rolfes
Prof dr EP van Puijenbroek
Prof dr K Taxis
Patient participation in pharmacovigilance

2018-03-16 Thang Nuyen
Prof dr K Taxis
Prof dr B Wilffert
Prof de TT Pham
Medication use for acute coronary syndrome in Vietnam

2018-01-26 Eva van Doorn
Prof dr E Hak
Prof dr ALW Huckriede
Improving influenza prevention. Why universal influenza vaccines are needed

2017-08-12 Jurjen van der Schans
Prof dr E Hak
Prof dr PJ Hoekstra
Dr TW de Vries
ADHD and atopic diseases. Pharmacoepidemiological studies

2017-06-02 Jan Peter Yska
Prof dr EN van Roon
Prof dr B Wilffert
Exploring optimal pharmacotherapy after bariatric surgery: where two worlds meet

2017-04-24 Nur Aizati Athirah Daud
Prof dr B Wilffert
Dr JEH Bergman
Paving ways for personalizing drug therapy during pregnancy

2016-03-11 Maarten Bijlsma
Prof dr E Hak
Prof dr S Vansteelandt
Age-period-cohort methodology: Confounding by birth cohort in cardiovascular pharmacoepidemiology

2016-03-02 Linda de Jong
Prof dr IM van Langen
Prof dr LTW de Jong- van den Berg
Data quality and methodology in studies on maternal medication use in relation to congenital anomalies

2016-02-26 Dianna de Vries
Prof dr E Hak
Prof dr P Denig
Prof dr MJ Postma
Statin treatment in type 2 diabetes patients

2016-02-19 Bianca Mulder
Prof dr E Hak
Prof dr SS Jick
Medication use during pregnancy and atopic diseases in childhood

2016-01-25 Priscilla Zetstra-van der Woude
Prof dr LTW de Jong-van den Berg
Data collection on risk factors in pregnancy

2015-12-04 Koen Pouwels
Prof dr E Hak
Self-controlled designs to control confounding

2015-09-25 Job van Boven
Prof dr MJ Postma
Prof dr T van der Molen
Enhancing adherence in patients with COPD: Targets, interventions & cost-effectiveness

2014-05-28 Giedre Gefenaite
Prof dr E Hak
Prof dr RP Stolk
Newly introduced vaccines. Effectiveness and deterninants of acceptance

2013-05-31 Josta de Jong
Prof dr LTW de Jong-van den Berg
Dr TW de Vries
Antibiotic drug use in children. Pharmacoepidemiologic, practical, social en enviromental perspectives in the Netherlands

2013-02-25 Mark Rozenbaum
Prof dr MJ Postma
Prof dr E Hak
Cost and Effectiveness of Extended Vaccination Strategies against Pertussis and Pneumococcal Disease

2013-01-11 Peter ter Horst
Prof dr B Wilffert
Prof dr LTW de Jong-van den Berg
Clinical Pharmacology of Antidepressants During Pregnancy

2012-11-16 Ineke Crijns
Prof dr LTW de Jong-van den Berg
Drug Related Safety Issues Affecting Precnancy Outcome and Concerning Risk Minimisation Measures. Emphasis on Pregnancy Prevention Programmes

2012-03-16 Stefan Vegter
Prof dr MJ Postma
Prof dr G Navis
The value of personalized approaches to improve pharmacotherapy in renal disease

2012-02-24 Silvia Ravera
Prof dr JJ de Gier
Prof dr LTW de Jong vd berg
Psychotropic medications and traffic safety. Contributions to risk assessment and risk communication

2011-12-09 Janneke Boersma-Jentink
Prof dr LTW de Jong vd berg
Prof dr H Dolk
Risk assessment of antiepileptic drugs in pregnancy

2010-01-11 Marian K. Bakker
prof dr  CHCM Buijs
Prof dr LTW de Jong van den berg
The use of a birth defects case-control monitoring system in studying the safety of medication use in pregnancy.

2009-06-12 Cornelis Boersma
Prof dr MJ Postma
Prof dr LTW de Jong van den berg
Prof dr PE de Jong
Health economics of cardiovascular & renal disease prevention : from clinical trials to real-life settings.

2009-03-20 Fokaline Vroom
Prof dr LTW de Jong-van den Berg
Prof dr JRBJ Brouwers
Prof dr MAFJ van de Laar
Drug use in pregnancy. Exploring the field of DMARDs in pregnancy.

2006-09-15 Jarir Atthobari
prof dr LTW de Jong-van den Berg
prof dr PE de Jong
Drug use in a population screening: Pharmacoepidemiological and pharmacoeconomical aspects.

2006-06-30 Rogier Klok
Prof dr JRBJ Brouwers
Prof dr MJ Postma
Pharmacoeconomic Analysis of Proton Pump Inhibitor Therapy and interventions to Control Helicobacter pylori Infection.

2006-10-02 Adrianne Faber
prof dr LTW de Jong-van den Berg
Stimulant treatment in children: a Dutch perspective.

2006-12-08 Willemijn Meijer
prof dr LTW de Jong-van den Berg
prof dr JRBJ Brouwers
Drug safety in pregnancy. Studying and communicating teratogenic risks.

2003-10-03 Claudia Rijcken
Prof dr LTW de Jong-van den Berg
Pharmacy Data as a Tool for assessing Antypsychotic Drug Use.

2003-10-03 Eric Schirm
Prof dr LTW de Jong-van den Berg
Dr H Tobi Drug
Exposure from conception till adulthood.